Alliance for Clinical Trials in Oncology
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2011-01-01
- Employees
- 251
- Market Cap
- -
Multidrug Resistance Genes in Patients With Acute Myeloid Leukemia
- Conditions
- Leukemia
- Interventions
- Genetic: gene expression analysisGenetic: molecular genetic techniqueGenetic: polymorphism analysisGenetic: protein expression analysisOther: diagnostic laboratory biomarker analysis
- First Posted Date
- 2009-05-12
- Last Posted Date
- 2023-08-18
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 600
- Registration Number
- NCT00898456
- Locations
- 🇺🇸
Fort Wayne Medical Oncology and Hematology, Fort Wayne, Indiana, United States
Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme
- Conditions
- Glioblastoma Multiforme
- Interventions
- First Posted Date
- 2009-05-04
- Last Posted Date
- 2019-10-21
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 144
- Registration Number
- NCT00892177
- Locations
- 🇺🇸
Kauai Medical Clinic, Lihue, Hawaii, United States
🇺🇸Wilcox Memorial Hospital and Kauai Medical Clinic, Lihue, Hawaii, United States
🇺🇸Castle Medical Center, Kailua, Hawaii, United States
Capecitabine With or Without Sunitinib Malate as First-Line Therapy in Treating Patients With Metastatic Cancer of the Esophagus or Gastroesophageal Junction
- Conditions
- Esophageal CancerAdenocarcinoma of the Gastroesophageal Junction
- Interventions
- First Posted Date
- 2009-05-01
- Last Posted Date
- 2018-07-24
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 12
- Registration Number
- NCT00891878
- Locations
- 🇺🇸
Memorial Hospital, Carthage, Illinois, United States
🇺🇸Graham Hospital, Canton, Illinois, United States
🇺🇸Illinois CancerCare - Havana, Havana, Illinois, United States
Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma
- Conditions
- Brain and Central Nervous System Tumors
- Interventions
- First Posted Date
- 2009-04-23
- Last Posted Date
- 2024-08-02
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 305
- Registration Number
- NCT00887146
- Locations
- 🇺🇸
Mount Carmel Health Center West, Columbus, Ohio, United States
🇺🇸Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States
🇺🇸Northwestern University, Chicago, Illinois, United States
Surgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II, Stage IIIA, or Stage IIIB Breast Cancer
- Conditions
- Breast Cancer
- Interventions
- Drug: systemic chemotherapyProcedure: axillary lymph node dissectionProcedure: neoadjuvant therapyProcedure: sentinel lymph node biopsyProcedure: therapeutic conventional surgeryProcedure: ultrasound imaging
- First Posted Date
- 2009-04-15
- Last Posted Date
- 2023-04-27
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 756
- Registration Number
- NCT00881361
- Locations
- 🇺🇸
Allegheny Cancer Center at Allegheny General Hospital, Pittsburgh, Pennsylvania, United States
🇺🇸Contra Costa Regional Medical Center, Martinez, California, United States
🇺🇸Mercy Medical Center, Baltimore, Maryland, United States
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
- Conditions
- Nausea and VomitingUnspecified Adult Solid Tumor, Protocol Specific
- Interventions
- First Posted Date
- 2009-04-13
- Last Posted Date
- 2016-07-06
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 430
- Registration Number
- NCT00880191
- Locations
- 🇺🇸
Marshfield Clinic - Weston Center, Weston, Wisconsin, United States
🇺🇸Hope Cancer Care Center at Longmont United Hospital, Longmont, Colorado, United States
🇺🇸Illinois CancerCare - Eureka, Eureka, Illinois, United States
Dasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- Conditions
- Brain and Central Nervous System Tumors
- Interventions
- First Posted Date
- 2009-03-26
- Last Posted Date
- 2020-02-13
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 217
- Registration Number
- NCT00869401
- Locations
- 🇺🇸
Helen and Harry Gray Cancer Center at Hartford Hospital, Hartford, Connecticut, United States
🇺🇸Illinois CancerCare - Canton, Canton, Illinois, United States
🇺🇸Licking Memorial Cancer Care Program at Licking Memorial Hospital, Newark, Ohio, United States
Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement
- Conditions
- Breast AdenocarcinomaDS Stage I Plasma Cell MyelomaDS Stage II Plasma Cell MyelomaUrinary ComplicationsMetastatic Malignant Neoplasm to the BonePainMusculoskeletal Complication
- Interventions
- First Posted Date
- 2009-03-25
- Last Posted Date
- 2018-11-07
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 1822
- Registration Number
- NCT00869206
- Locations
- 🇺🇸
Winship Cancer Institute of Emory University, Atlanta, Georgia, United States
🇺🇸Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
🇺🇸CCOP - Columbus, Columbus, Ohio, United States
Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer
- First Posted Date
- 2009-03-23
- Last Posted Date
- 2022-04-19
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 24
- Registration Number
- NCT00867321
- Locations
- 🇺🇸
Illinois CancerCare - Community Cancer Center, Normal, Illinois, United States
🇺🇸Community Hospital of Ottawa, Ottawa, Illinois, United States
🇺🇸Cancer Center of Kansas, PA - Wellington, Wellington, Kansas, United States
Chemotherapy or Observation in Treating Patients With Early Stage Non-Small Cell Lung Cancer
- Conditions
- Lung Cancer
- Interventions
- Procedure: standard follow-up care
- First Posted Date
- 2009-03-18
- Last Posted Date
- 2017-03-27
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 34
- Registration Number
- NCT00863512
- Locations
- 🇺🇸
Good Samaritan Cancer Center, Puyallup, Washington, United States
🇺🇸Alvin and Lois Lapidus Cancer Institute at Sinai Hospital, Baltimore, Maryland, United States
🇺🇸Medical City Dallas Hospital, Dallas, Texas, United States